All these results suggest that the CRP value is a useful prognosis biomarker of DCM patients, and there are few data regarding the utility of plasma CRP levels, as a prognostic marker, specifically in patients with NIDCM. The gene discussed is CRP; the disease is familial dilated cardiomyopathy.